1.Experience of treatment for common bile duct stones by laparoscope combined with choledochoscope
Deshu WANG ; Shuangyong CAI ; Wenhao CHEN ; Jun ZHANG ; Guanbo CAO ; Jun WU
Journal of Regional Anatomy and Operative Surgery 2015;(4):445-446
Objective To summarize the effect of treatment for common bile duct stones by laparoscope combined with choledocho-scope, and to assess the feasibility in judgment the patency of common bile duct by stone basket. Methods To review and analyze the clini-cal data of 32 patients who were given choledocholithiasis operation through laparoscope combined with choledochoscope,and the operation method,effect and complications were compared. Results In this research,32 choledocholithiasis operations were carried out using laparo-scope combined with choledochoscope from January 2013 to January 2014. The stones of 31 patients were taken out completely,and there were no stone in the other patient. All 32 patients recovered without any complication. After operation,all 32 patients showed unrestricted inferior bile common duct and no residual stone by T-tube cholangiography. Conclusion It showed satisfactory effect in treatment of choledocholithi-asis by laparoscope combined with choledochoscope. Compared to traditional laparotomy,which showed less injure and faster recovery. It is a simple and feasible method to judge the patency of common bile duct using large size stone basket combined with methylene blue injection.
2.The relationship between the antipituitary antibodies (APAs) and hypopituitarism after traumatic brain injury
Mingjun ZHANG ; Guanbai CAO ; Ling FENG ; Qiaoling HU ; Deshu WANG ; Jun WU ; Wenhao CHEN
Chinese Journal of Microbiology and Immunology 2012;(12):1071-1073
Objective To investigate the relationship between antipituitary antibodies (APAs) and hypopituiarism following traumatic brain injury (TBI),as well as the severity of brain injury.Methods The study included 73 patients who suffered TBI 9 to 12 months ago and were diagnosed with hypopituitarism during the follow-up.Based on their Glasgow Coma Scale (GCS) on admission they were categorized into three groups:A (3-8),B (9-12) and C (13-15).Levels of plasma pituitary hormones (GH,TT,FT3 and FSH/LH) and APAs were measured in all patients with chemiluminescence assays and ELISA,respectively.Results Patients in group A had higher levels of APAs and lower levels of hormones compared with those in group B(P<0.001) or group C(P<0.001),while no significant difference was found between group B and group C for levels of either APAs (P>0.05) or hormones (P>0.05).Levels of APAs were negatively correlated with both GH (r=-0.64071,P<0.001) and GCS (r=-0.50132,P<0.001).Conclusion The present investigation provides preliminary evidence that APAs may be associated with the development of TBI-induced hypopituiarism.It suggests that the severity of hypopituiarism following TBI could be predicted by measuring the level of APAs.
3.Diagnosis and treatment of acute kidney injury after liver transplantation
Jinzhen CAI ; Zhiqiang LI ; Chuanshen XU ; Kai ZHAO ; Deshu DAI ; Xin WANG
Organ Transplantation 2023;14(4):473-
Acute kidney injury is a common complication after liver transplantation, which severely affects clinical prognosis of liver transplant recipients. Multiple factors before, during and after liver transplantation may cause kidney injury. If not properly treated, it may progress into chronic kidney diseases, which significantly increases postoperative fatality and negatively affects clinical efficacy of liver transplantation. Therefore, prevention, diagnosis and treatment of acute kidney injury after liver transplantation is a hot topic for clinicians. In this article, the definition, diagnosis, risk factors, prevention and treatment of acute kidney injury after liver transplantation were reviewed, and potential risk factors and related therapeutic strategies during different stages of acute kidney injury after liver transplantation were analyzed, aiming to lower the risk of acute kidney injury after liver transplantation and further improve clinical prognosis of liver transplant recipients by optimizing treatment regimens.
4.Influencing factors of liver regeneration and their prognostic impact after split liver transplantation
Lianghao ZHANG ; Qingguo XU ; Xin WANG ; Yong ZHANG ; Feng WANG ; Peng LIU ; Deshu DAI ; Bingni LI ; Xianjun ZHOU ; Jinzhen CAI
Chinese Journal of Hepatobiliary Surgery 2022;28(6):413-418
Objective:To study the influencing factors of liver regeneration and their prognostic impact after split liver transplantation.Methods:The clinical data of 44 patients who underwent split liver transplantation at the Organ Transplant Center of Affiliated Hospital of Qingdao University from January 2015 to July 2021 were analysed. There were 19 males and 25 females, aged (49±12) years old. Based on whether the liver regeneration rate (LRR) was greater than 100%, these patients were divided into the good regeneration group (LRR≥100%, n=24) and the poor regeneration group (LRR<100%, n=20). The differences in the perioperative data and postoperative survival rates between the two groups were compared. The patients were followed up by outpatient reexamination or telephone. Results:On days 15, 30, 90, and 180 after operation, the volume change rates in the transplanted liver were (117.04±7.00)%, (164.03±16.72)%, (180.98±26.30)%, (159.40±26.28)%, respectively. The body mass index, anhepatic period, intraoperative bleeding, intraoperative blood transfusion, hospitalization time, recovery time of liver function, fatty degeneration of donor liver and type of donor liver were the influencing factors of liver regenera-tion after split liver transplantation. The levels of aspartate aminotransferase and alanine aminotransferase on the days 1, 2, 3, 4, 5, 6 and 7 after operation in the group of patient with good regeneration were significantly lower than those in the group of patient with poor regeneration ( P<0.05). The levels of total bilirubin in the group of patient with good regeneration was significantly lower than those in the group of patient with poor regeneration on days 5, 6 and 7 after operation ( P<0.05). The portal vein flow per 100 g of liver mass in the good regeneration group was significantly better than the poor regeneration group on day 1 and 30 after operation. The 6-month cumulative survival rates of the good regeneration group and the poor regeneration group were 95.8% and 70.0% respectively, and the difference was significant ( P=0.017). Conclusions:Body mass index, anhepatic period, intraoperative blood loss, intraoperative blood transfusion, hospitalization time, recovery time of liver function, fatty degeneration of donor liver and type of donor liver were the influencing factors of liver regeneration after split liver transplantation. The prognosis of recipients with poor liver regeneration was significantly worse than recipients with good liver regeneration.
5.Diagnosis and treatment of unicentric hepatic Castleman disease
Rui LI ; Yongfu LI ; Jun ZHANG ; Shuangyong CAI ; Jun WU ; Deshu WANG
Chinese Journal of Digestive Surgery 2023;22(S1):87-90
Unicentric Castleman disease (CD) is a rarely abnormal lymphoproliferative disease with unknown etiology and hyaline vascular variant is the most common histopathological type. The clinical manifestations of unicentric CD are solitary masses with slow growth, mainly occurring in the mediastinum, abdominal cavity, retroperitoneum, pelvis, and neck. Application of multidisciplinary cooperation between surgical, radiologic, pathological and oncological experts is necessary for the diagnosis and treatment of unicentric CD, in order to achieve good treatment results. The best treatment method for unicentric CD is surgical resection. With the accumulation of experience and technological progress, there may be more precise and minimally invasive surgical methods such as laparoscopic or robotic techniques besides open surgery. The authors report the diagnosis and treatment of unicentric hepatic CD, aiming to provide reference for related treatments.
6.Successful trans-blood liver transplantation after artificial liver support therapy in a patient with hepatic coma: A case report
Shuang SUN ; Jinquan LIU ; Shuai FENG ; Shuxian WANG ; Xiangmei XU ; Deshu DAI ; Jianhong WANG ; Jinzhen CAI ; Chuanshen XU
Journal of Clinical Hepatology 2024;40(4):791-793
This article reports a patient with hepatic coma who underwent artificial liver support therapy and liver transplantation successfully, and the patient recovered well in the later stage after active treatment. This article also discusses the timing of liver transplantation.